Blue Jet Healthcare Ltd
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.[1]
- Market Cap ₹ 12,804 Cr.
- Current Price ₹ 737
- High / Low ₹ 1,028 / 460
- Stock P/E 90.9
- Book Value ₹
- Dividend Yield 0.16 %
- ROCE 57.3 %
- ROE 52.1 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | |
---|---|---|
538 | 499 | |
324 | 293 | |
Operating Profit | 214 | 206 |
OPM % | 40% | 41% |
6 | 4 | |
Interest | 7 | 5 |
Depreciation | 18 | 20 |
Profit before tax | 194 | 185 |
Tax % | 25% | 26% |
145 | 136 | |
EPS in Rs | 24,141.67 | 1,396.49 |
Dividend Payout % | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -7% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -3% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 56% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 52% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | |
---|---|---|
Equity Capital | 0.60 | 10 |
Reserves | 201 | 330 |
79 | 53 | |
95 | 143 | |
Total Liabilities | 375 | 536 |
107 | 139 | |
CWIP | 2 | 3 |
Investments | 34 | 37 |
232 | 358 | |
Total Assets | 375 | 536 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | |
---|---|---|
123 | 129 | |
-45 | -51 | |
-72 | -28 | |
Net Cash Flow | 5 | 51 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | |
---|---|---|
Debtor Days | 80 | 105 |
Inventory Days | 120 | 253 |
Days Payable | 90 | 128 |
Cash Conversion Cycle | 110 | 231 |
Working Capital Days | 51 | 88 |
ROCE % | 57% |
Documents
Announcements
-
Appointment Of Secretarial Auditor
22 Aug - Board approved Rs1.2/share dividend (60%); director appointments; AGM Sept 26, 2025; record date Sept 19, 2025.
- Corporate Action - Fixed Record Date For Dividend As September 19, 2025 22 Aug
-
Announcement under Regulation 30 (LODR)-Change in Directorate
22 Aug - Board approved reappointments/re-designations, secretarial auditor; record date Sept 19, 2025; final dividend Rs1.2/share paid by Oct 25, 2025.
-
Board Meeting Outcome for Board Meeting Outcome
22 Aug - Board approved secretarial auditor appointment; director re-appointments/re-designations; Record Date Sept 19, 2025 for Rs.1.2/share dividend; AGM Sept 26, 2025.
-
Announcement Under Regulation 30 - Acquisition Of Land And Investment Approval
31 Jul - Blue Jet approves 102.48-acre land acquisition and up to INR 1000 Cr capex for new manufacturing facility by FY 28-29.
Concalls
-
Jul 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT
Product Portfolio
A) Contrast Media Intermediates (67.7% of FY24 revenue)[1]
Contrast media are chemical agents that enhance imaging clarity for diagnostic purposes, making tissues more visible under X-rays, CT scans, MRIs, and ultrasounds. The company supplies critical starting and advanced intermediates to the world's top contrast media manufacturers.